Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pacritinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for Pacritinib avoiding Grubbs catalyst. Cost-effective, scalable process for high-purity API intermediates suitable for commercial manufacturing.
Novel cyclization route for Pacritinib intermediates ensures high purity and scalable production. Eliminating precious metal catalysts reduces costs significantly for supply chains.